Optimizing Arginine Deprivation for Hard-To-Treat Cancers

Oncotarget- United States

doi 10.18632/oncotarget.22099

Full Text

Abstract

Available in

Categories

Date

October 27, 2017

Authors

Peter W. Szlosarek

Publisher

Impact Journals, LLC

Related search

High-Throughput Genomics and Clinical Outcome in Hard-To-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

Cancer Discovery

English

Arginine Deprivation as a Targeted Therapy for Cancer

Current Pharmaceutical Design

English

Encapsulated Irinotecan Provides Novel Option for Hard-To-Treat Pancreatic Cancer

Journal of Community and Supportive Oncology

English

Arginine-Deprivation–induced Oxidative Damage sterilizesMycobacterium Tuberculosis

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

How We Treat Germ Cell Cancers

Cancer Research

English

Optimizing Pred(25) Is NP-Hard

Studies in Systems, Decision and Control

Systems Engineering

Automotive Engineering

Decision Sciences

Computer Science

Social Sciences

English

How I Treat Cancers of Unknown Primary

Cancer Research

English

Hard Decoding Algorithm for Optimizing Thresholds Under General Markovian Noise

Physical Review A

Molecular Physics,

English

Influence of Arginine Metabolites on Human Tumar Cell Viability Upon Arginine Deprivation in Vitro

Studia Biologica

English